Global AI Pathology Software Supply, Demand and Key Producers, 2026-2032
The global AI Pathology Software market size is expected to reach $ 571 million by 2032, rising at a market growth of 6.6% CAGR during the forecast period (2026-2032).
AI Pathology Software refers to software systems that utilize deep learning, computer vision, image recognition, digital pathology analysis, and medical knowledge models to perform automated recognition, quantitative analysis, and diagnostic support on pathological slides, whole-slide images (WSI), immunohistochemistry (IHC) images, cytology images, and molecular pathology data. These systems are used for applications such as tumor region identification, cell counting, tissue typing, lesion detection, grading and scoring, biomarker quantification, prognosis assessment, and treatment decision support. Their core objectives are to enhance diagnostic efficiency, reduce the manual workload of slide review, improve result consistency and reproducibility, and assist physicians in making more precise clinical judgments; they are widely deployed in hospital pathology departments, third-party medical testing laboratories, pharmaceutical R&D, clinical trials, and research institutions.
The global AI pathology software market is characterized by North American leadership, standardized advancement in Europe, and rapid growth in the Asia-Pacific region. Driven by the widespread adoption of digital pathology equipment, strong R&D capabilities in medical AI, and demand for clinical trials, North American applications focus on AI-assisted cancer diagnosis, quantitative immunohistochemistry, drug development, and remote pathology consultation. The European market places greater emphasis on medical device approval, data compliance, clinical validation, and standardized diagnostic workflows. The Asia-Pacific region holds significant market potential, propelled by hospital digitalization, rising demand for cancer screening, a shortage of pathologists, and the development of 'smart hospitals.' The market is currently evolving from simple lesion detection toward comprehensive digital pathology platforms, multi-cancer diagnostic support, multimodal pathology analysis, and decision support for precision medicine. Future trends include automated whole-slide image analysis, AI-assisted tumor grading, the integration of pathology and genomic data, cloud-based remote pathology, companion diagnostics, and automated pathology analysis for clinical trials. Key challenges include the high cost of digital slide scanning equipment, difficulties in annotating pathology data, limited algorithm generalization capabilities, lengthy regulatory approval processes, complex hospital system integration, and varying levels of physician acceptance. The industry's average gross margin typically ranges from 55% to 80%; standardized software licensing and SaaS platforms command higher margins, whereas custom algorithm development, clinical validation, and system integration projects yield relatively lower margins.
This report studies the global AI Pathology Software demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for AI Pathology Software, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of AI Pathology Software that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global AI Pathology Software total market, 2021-2032, (USD Million)
Global AI Pathology Software total market by region & country, CAGR, 2021-2032, (USD Million)
U.S. VS China: AI Pathology Software total market, key domestic companies, and share, (USD Million)
Global AI Pathology Software revenue by player, revenue and market share 2021-2026, (USD Million)
Global AI Pathology Software total market by Type, CAGR, 2021-2032, (USD Million)
Global AI Pathology Software total market by Application, CAGR, 2021-2032, (USD Million)
This report profiles major players in the global AI Pathology Software market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include PathAI, Inc., Paige AI, Inc., Indica Labs, Aiforia Technologies Plc, Ibex Medical Analytics Ltd., Proscia Inc., Philips, Roche Diagnostics International Ltd, Leica Biosystems Nussloch GmbH, Fujifilm Holdings Corporation, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world AI Pathology Software market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global AI Pathology Software Market, By Region:
1. How big is the global AI Pathology Software market?
2. What is the demand of the global AI Pathology Software market?
3. What is the year over year growth of the global AI Pathology Software market?
4. What is the total value of the global AI Pathology Software market?
5. Who are the Major Players in the global AI Pathology Software market?
6. What are the growth factors driving the market demand?
AI Pathology Software refers to software systems that utilize deep learning, computer vision, image recognition, digital pathology analysis, and medical knowledge models to perform automated recognition, quantitative analysis, and diagnostic support on pathological slides, whole-slide images (WSI), immunohistochemistry (IHC) images, cytology images, and molecular pathology data. These systems are used for applications such as tumor region identification, cell counting, tissue typing, lesion detection, grading and scoring, biomarker quantification, prognosis assessment, and treatment decision support. Their core objectives are to enhance diagnostic efficiency, reduce the manual workload of slide review, improve result consistency and reproducibility, and assist physicians in making more precise clinical judgments; they are widely deployed in hospital pathology departments, third-party medical testing laboratories, pharmaceutical R&D, clinical trials, and research institutions.
The global AI pathology software market is characterized by North American leadership, standardized advancement in Europe, and rapid growth in the Asia-Pacific region. Driven by the widespread adoption of digital pathology equipment, strong R&D capabilities in medical AI, and demand for clinical trials, North American applications focus on AI-assisted cancer diagnosis, quantitative immunohistochemistry, drug development, and remote pathology consultation. The European market places greater emphasis on medical device approval, data compliance, clinical validation, and standardized diagnostic workflows. The Asia-Pacific region holds significant market potential, propelled by hospital digitalization, rising demand for cancer screening, a shortage of pathologists, and the development of 'smart hospitals.' The market is currently evolving from simple lesion detection toward comprehensive digital pathology platforms, multi-cancer diagnostic support, multimodal pathology analysis, and decision support for precision medicine. Future trends include automated whole-slide image analysis, AI-assisted tumor grading, the integration of pathology and genomic data, cloud-based remote pathology, companion diagnostics, and automated pathology analysis for clinical trials. Key challenges include the high cost of digital slide scanning equipment, difficulties in annotating pathology data, limited algorithm generalization capabilities, lengthy regulatory approval processes, complex hospital system integration, and varying levels of physician acceptance. The industry's average gross margin typically ranges from 55% to 80%; standardized software licensing and SaaS platforms command higher margins, whereas custom algorithm development, clinical validation, and system integration projects yield relatively lower margins.
This report studies the global AI Pathology Software demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for AI Pathology Software, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of AI Pathology Software that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global AI Pathology Software total market, 2021-2032, (USD Million)
Global AI Pathology Software total market by region & country, CAGR, 2021-2032, (USD Million)
U.S. VS China: AI Pathology Software total market, key domestic companies, and share, (USD Million)
Global AI Pathology Software revenue by player, revenue and market share 2021-2026, (USD Million)
Global AI Pathology Software total market by Type, CAGR, 2021-2032, (USD Million)
Global AI Pathology Software total market by Application, CAGR, 2021-2032, (USD Million)
This report profiles major players in the global AI Pathology Software market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include PathAI, Inc., Paige AI, Inc., Indica Labs, Aiforia Technologies Plc, Ibex Medical Analytics Ltd., Proscia Inc., Philips, Roche Diagnostics International Ltd, Leica Biosystems Nussloch GmbH, Fujifilm Holdings Corporation, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world AI Pathology Software market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global AI Pathology Software Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Histopathology AI Analysis Software
- Cytopathology AI Analysis Software
- Immunohistochemistry AI Analysis Software
- Molecular Pathology AI Analysis Software
- ?500 WSIs/Day
- 501?5,000 WSIs/Day
- >5,000 WSIs/Day
- Hospital Pathology Department
- Third-party Medical Testing Laboratory
- Pharmaceutical R&D
- PathAI, Inc.
- Paige AI, Inc.
- Indica Labs
- Aiforia Technologies Plc
- Ibex Medical Analytics Ltd.
- Proscia Inc.
- Philips
- Roche Diagnostics International Ltd
- Leica Biosystems Nussloch GmbH
- Fujifilm Holdings Corporation
- Visiopharm A/S
- Tempus AI, Inc.
- Yitu Technology Co., Ltd.
- Deepwise Healthcare Technology Co., Ltd.
1. How big is the global AI Pathology Software market?
2. What is the demand of the global AI Pathology Software market?
3. What is the year over year growth of the global AI Pathology Software market?
4. What is the total value of the global AI Pathology Software market?
5. Who are the Major Players in the global AI Pathology Software market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 AI Pathology Software Introduction
1.2 World AI Pathology Software Market Size & Forecast (2021 & 2025 & 2032)
1.3 World AI Pathology Software Total Market by Region (by Headquarter Location)
1.3.1 World AI Pathology Software Market Size by Region (2021-2032), (by Headquarter Location)
1.3.2 United States Based Company AI Pathology Software Revenue (2021-2032)
1.3.3 China Based Company AI Pathology Software Revenue (2021-2032)
1.3.4 Europe Based Company AI Pathology Software Revenue (2021-2032)
1.3.5 Japan Based Company AI Pathology Software Revenue (2021-2032)
1.3.6 South Korea Based Company AI Pathology Software Revenue (2021-2032)
1.3.7 ASEAN Based Company AI Pathology Software Revenue (2021-2032)
1.3.8 India Based Company AI Pathology Software Revenue (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 AI Pathology Software Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Major Market Trends
2 DEMAND SUMMARY
2.1 World AI Pathology Software Consumption Value (2021-2032)
2.2 World AI Pathology Software Consumption Value by Region
2.2.1 World AI Pathology Software Consumption Value by Region (2021-2026)
2.2.2 World AI Pathology Software Consumption Value Forecast by Region (2027-2032)
2.3 United States AI Pathology Software Consumption Value (2021-2032)
2.4 China AI Pathology Software Consumption Value (2021-2032)
2.5 Europe AI Pathology Software Consumption Value (2021-2032)
2.6 Japan AI Pathology Software Consumption Value (2021-2032)
2.7 South Korea AI Pathology Software Consumption Value (2021-2032)
2.8 ASEAN AI Pathology Software Consumption Value (2021-2032)
2.9 India AI Pathology Software Consumption Value (2021-2032)
3 WORLD AI PATHOLOGY SOFTWARE COMPANIES COMPETITIVE ANALYSIS
3.1 World AI Pathology Software Revenue by Player (2021-2026)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global AI Pathology Software Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for AI Pathology Software in 2025
3.2.3 Global Concentration Ratios (CR8) for AI Pathology Software in 2025
3.3 AI Pathology Software Company Evaluation Quadrant
3.4 AI Pathology Software Market: Overall Company Footprint Analysis
3.4.1 AI Pathology Software Market: Region Footprint
3.4.2 AI Pathology Software Market: Company Product Type Footprint
3.4.3 AI Pathology Software Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: AI Pathology Software Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: AI Pathology Software Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
4.1.2 United States VS China: AI Pathology Software Revenue Market Share Comparison (2021 & 2025 & 2032)
4.2 United States Based Companies VS China Based Companies: AI Pathology Software Consumption Value Comparison
4.2.1 United States VS China: AI Pathology Software Consumption Value Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: AI Pathology Software Consumption Value Market Share Comparison (2021 & 2025 & 2032)
4.3 United States Based AI Pathology Software Companies and Market Share, 2021-2026
4.3.1 United States Based AI Pathology Software Companies, Headquarters (States, Country)
4.3.2 United States Based Companies AI Pathology Software Revenue, (2021-2026)
4.4 China Based Companies AI Pathology Software Revenue and Market Share, 2021-2026
4.4.1 China Based AI Pathology Software Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies AI Pathology Software Revenue, (2021-2026)
4.5 Rest of World Based AI Pathology Software Companies and Market Share, 2021-2026
4.5.1 Rest of World Based AI Pathology Software Companies, Headquarters (Province, Country)
4.5.2 Rest of World Based Companies AI Pathology Software Revenue (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World AI Pathology Software Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Histopathology AI Analysis Software
5.2.2 Cytopathology AI Analysis Software
5.2.3 Immunohistochemistry AI Analysis Software
5.2.4 Molecular Pathology AI Analysis Software
5.3 Market Segment by Type
5.3.1 World AI Pathology Software Market Size by Type (2021-2026)
5.3.2 World AI Pathology Software Market Size by Type (2027-2032)
5.3.3 World AI Pathology Software Market Size Market Share by Type (2027-2032)
6 MARKET ANALYSIS BY PROCESSING CAPACITY
6.1 World AI Pathology Software Market Size Overview by Processing Capacity: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Processing Capacity
6.2.1 ?500 WSIs/Day
6.2.2 501?5,000 WSIs/Day
6.2.3 >5,000 WSIs/Day
6.3 Market Segment by Processing Capacity
6.3.1 World AI Pathology Software Market Size by Processing Capacity (2021-2026)
6.3.2 World AI Pathology Software Market Size by Processing Capacity (2027-2032)
6.3.3 World AI Pathology Software Market Size Market Share by Processing Capacity (2027-2032)
7 MARKET ANALYSIS BY APPLICATION
7.1 World AI Pathology Software Market Size Overview by Application: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Application
7.2.1 Hospital Pathology Department
7.2.2 Third-party Medical Testing Laboratory
7.2.3 Pharmaceutical R&D
7.3 Market Segment by Application
7.3.1 World AI Pathology Software Market Size by Application (2021-2026)
7.3.2 World AI Pathology Software Market Size by Application (2027-2032)
7.3.3 World AI Pathology Software Market Size Market Share by Application (2021-2032)
8 COMPANY PROFILES
8.1 PathAI, Inc.
8.1.1 PathAI, Inc. Details
8.1.2 PathAI, Inc. Major Business
8.1.3 PathAI, Inc. AI Pathology Software Product and Services
8.1.4 PathAI, Inc. AI Pathology Software Revenue, Gross Margin and Market Share (2021-2026)
8.1.5 PathAI, Inc. Recent Developments/Updates
8.1.6 PathAI, Inc. Competitive Strengths & Weaknesses
8.2 Paige AI, Inc.
8.2.1 Paige AI, Inc. Details
8.2.2 Paige AI, Inc. Major Business
8.2.3 Paige AI, Inc. AI Pathology Software Product and Services
8.2.4 Paige AI, Inc. AI Pathology Software Revenue, Gross Margin and Market Share (2021-2026)
8.2.5 Paige AI, Inc. Recent Developments/Updates
8.2.6 Paige AI, Inc. Competitive Strengths & Weaknesses
8.3 Indica Labs
8.3.1 Indica Labs Details
8.3.2 Indica Labs Major Business
8.3.3 Indica Labs AI Pathology Software Product and Services
8.3.4 Indica Labs AI Pathology Software Revenue, Gross Margin and Market Share (2021-2026)
8.3.5 Indica Labs Recent Developments/Updates
8.3.6 Indica Labs Competitive Strengths & Weaknesses
8.4 Aiforia Technologies Plc
8.4.1 Aiforia Technologies Plc Details
8.4.2 Aiforia Technologies Plc Major Business
8.4.3 Aiforia Technologies Plc AI Pathology Software Product and Services
8.4.4 Aiforia Technologies Plc AI Pathology Software Revenue, Gross Margin and Market Share (2021-2026)
8.4.5 Aiforia Technologies Plc Recent Developments/Updates
8.4.6 Aiforia Technologies Plc Competitive Strengths & Weaknesses
8.5 Ibex Medical Analytics Ltd.
8.5.1 Ibex Medical Analytics Ltd. Details
8.5.2 Ibex Medical Analytics Ltd. Major Business
8.5.3 Ibex Medical Analytics Ltd. AI Pathology Software Product and Services
8.5.4 Ibex Medical Analytics Ltd. AI Pathology Software Revenue, Gross Margin and Market Share (2021-2026)
8.5.5 Ibex Medical Analytics Ltd. Recent Developments/Updates
8.5.6 Ibex Medical Analytics Ltd. Competitive Strengths & Weaknesses
8.6 Proscia Inc.
8.6.1 Proscia Inc. Details
8.6.2 Proscia Inc. Major Business
8.6.3 Proscia Inc. AI Pathology Software Product and Services
8.6.4 Proscia Inc. AI Pathology Software Revenue, Gross Margin and Market Share (2021-2026)
8.6.5 Proscia Inc. Recent Developments/Updates
8.6.6 Proscia Inc. Competitive Strengths & Weaknesses
8.7 Philips
8.7.1 Philips Details
8.7.2 Philips Major Business
8.7.3 Philips AI Pathology Software Product and Services
8.7.4 Philips AI Pathology Software Revenue, Gross Margin and Market Share (2021-2026)
8.7.5 Philips Recent Developments/Updates
8.7.6 Philips Competitive Strengths & Weaknesses
8.8 Roche Diagnostics International Ltd
8.8.1 Roche Diagnostics International Ltd Details
8.8.2 Roche Diagnostics International Ltd Major Business
8.8.3 Roche Diagnostics International Ltd AI Pathology Software Product and Services
8.8.4 Roche Diagnostics International Ltd AI Pathology Software Revenue, Gross Margin and Market Share (2021-2026)
8.8.5 Roche Diagnostics International Ltd Recent Developments/Updates
8.8.6 Roche Diagnostics International Ltd Competitive Strengths & Weaknesses
8.9 Leica Biosystems Nussloch GmbH
8.9.1 Leica Biosystems Nussloch GmbH Details
8.9.2 Leica Biosystems Nussloch GmbH Major Business
8.9.3 Leica Biosystems Nussloch GmbH AI Pathology Software Product and Services
8.9.4 Leica Biosystems Nussloch GmbH AI Pathology Software Revenue, Gross Margin and Market Share (2021-2026)
8.9.5 Leica Biosystems Nussloch GmbH Recent Developments/Updates
8.9.6 Leica Biosystems Nussloch GmbH Competitive Strengths & Weaknesses
8.10 Fujifilm Holdings Corporation
8.10.1 Fujifilm Holdings Corporation Details
8.10.2 Fujifilm Holdings Corporation Major Business
8.10.3 Fujifilm Holdings Corporation AI Pathology Software Product and Services
8.10.4 Fujifilm Holdings Corporation AI Pathology Software Revenue, Gross Margin and Market Share (2021-2026)
8.10.5 Fujifilm Holdings Corporation Recent Developments/Updates
8.10.6 Fujifilm Holdings Corporation Competitive Strengths & Weaknesses
8.11 Visiopharm A/S
8.11.1 Visiopharm A/S Details
8.11.2 Visiopharm A/S Major Business
8.11.3 Visiopharm A/S AI Pathology Software Product and Services
8.11.4 Visiopharm A/S AI Pathology Software Revenue, Gross Margin and Market Share (2021-2026)
8.11.5 Visiopharm A/S Recent Developments/Updates
8.11.6 Visiopharm A/S Competitive Strengths & Weaknesses
8.12 Tempus AI, Inc.
8.12.1 Tempus AI, Inc. Details
8.12.2 Tempus AI, Inc. Major Business
8.12.3 Tempus AI, Inc. AI Pathology Software Product and Services
8.12.4 Tempus AI, Inc. AI Pathology Software Revenue, Gross Margin and Market Share (2021-2026)
8.12.5 Tempus AI, Inc. Recent Developments/Updates
8.12.6 Tempus AI, Inc. Competitive Strengths & Weaknesses
8.13 Yitu Technology Co., Ltd.
8.13.1 Yitu Technology Co., Ltd. Details
8.13.2 Yitu Technology Co., Ltd. Major Business
8.13.3 Yitu Technology Co., Ltd. AI Pathology Software Product and Services
8.13.4 Yitu Technology Co., Ltd. AI Pathology Software Revenue, Gross Margin and Market Share (2021-2026)
8.13.5 Yitu Technology Co., Ltd. Recent Developments/Updates
8.13.6 Yitu Technology Co., Ltd. Competitive Strengths & Weaknesses
8.14 Deepwise Healthcare Technology Co., Ltd.
8.14.1 Deepwise Healthcare Technology Co., Ltd. Details
8.14.2 Deepwise Healthcare Technology Co., Ltd. Major Business
8.14.3 Deepwise Healthcare Technology Co., Ltd. AI Pathology Software Product and Services
8.14.4 Deepwise Healthcare Technology Co., Ltd. AI Pathology Software Revenue, Gross Margin and Market Share (2021-2026)
8.14.5 Deepwise Healthcare Technology Co., Ltd. Recent Developments/Updates
8.14.6 Deepwise Healthcare Technology Co., Ltd. Competitive Strengths & Weaknesses
9 INDUSTRY CHAIN ANALYSIS
9.1 AI Pathology Software Industry Chain
9.2 AI Pathology Software Upstream Analysis
9.3 AI Pathology Software Midstream Analysis
9.4 AI Pathology Software Downstream Analysis
10 RESEARCH FINDINGS AND CONCLUSION
11 APPENDIX
11.1 Methodology
11.2 Research Process and Data Source
11.3 Disclaimer
1.1 AI Pathology Software Introduction
1.2 World AI Pathology Software Market Size & Forecast (2021 & 2025 & 2032)
1.3 World AI Pathology Software Total Market by Region (by Headquarter Location)
1.3.1 World AI Pathology Software Market Size by Region (2021-2032), (by Headquarter Location)
1.3.2 United States Based Company AI Pathology Software Revenue (2021-2032)
1.3.3 China Based Company AI Pathology Software Revenue (2021-2032)
1.3.4 Europe Based Company AI Pathology Software Revenue (2021-2032)
1.3.5 Japan Based Company AI Pathology Software Revenue (2021-2032)
1.3.6 South Korea Based Company AI Pathology Software Revenue (2021-2032)
1.3.7 ASEAN Based Company AI Pathology Software Revenue (2021-2032)
1.3.8 India Based Company AI Pathology Software Revenue (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 AI Pathology Software Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Major Market Trends
2 DEMAND SUMMARY
2.1 World AI Pathology Software Consumption Value (2021-2032)
2.2 World AI Pathology Software Consumption Value by Region
2.2.1 World AI Pathology Software Consumption Value by Region (2021-2026)
2.2.2 World AI Pathology Software Consumption Value Forecast by Region (2027-2032)
2.3 United States AI Pathology Software Consumption Value (2021-2032)
2.4 China AI Pathology Software Consumption Value (2021-2032)
2.5 Europe AI Pathology Software Consumption Value (2021-2032)
2.6 Japan AI Pathology Software Consumption Value (2021-2032)
2.7 South Korea AI Pathology Software Consumption Value (2021-2032)
2.8 ASEAN AI Pathology Software Consumption Value (2021-2032)
2.9 India AI Pathology Software Consumption Value (2021-2032)
3 WORLD AI PATHOLOGY SOFTWARE COMPANIES COMPETITIVE ANALYSIS
3.1 World AI Pathology Software Revenue by Player (2021-2026)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global AI Pathology Software Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for AI Pathology Software in 2025
3.2.3 Global Concentration Ratios (CR8) for AI Pathology Software in 2025
3.3 AI Pathology Software Company Evaluation Quadrant
3.4 AI Pathology Software Market: Overall Company Footprint Analysis
3.4.1 AI Pathology Software Market: Region Footprint
3.4.2 AI Pathology Software Market: Company Product Type Footprint
3.4.3 AI Pathology Software Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: AI Pathology Software Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: AI Pathology Software Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
4.1.2 United States VS China: AI Pathology Software Revenue Market Share Comparison (2021 & 2025 & 2032)
4.2 United States Based Companies VS China Based Companies: AI Pathology Software Consumption Value Comparison
4.2.1 United States VS China: AI Pathology Software Consumption Value Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: AI Pathology Software Consumption Value Market Share Comparison (2021 & 2025 & 2032)
4.3 United States Based AI Pathology Software Companies and Market Share, 2021-2026
4.3.1 United States Based AI Pathology Software Companies, Headquarters (States, Country)
4.3.2 United States Based Companies AI Pathology Software Revenue, (2021-2026)
4.4 China Based Companies AI Pathology Software Revenue and Market Share, 2021-2026
4.4.1 China Based AI Pathology Software Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies AI Pathology Software Revenue, (2021-2026)
4.5 Rest of World Based AI Pathology Software Companies and Market Share, 2021-2026
4.5.1 Rest of World Based AI Pathology Software Companies, Headquarters (Province, Country)
4.5.2 Rest of World Based Companies AI Pathology Software Revenue (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World AI Pathology Software Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Histopathology AI Analysis Software
5.2.2 Cytopathology AI Analysis Software
5.2.3 Immunohistochemistry AI Analysis Software
5.2.4 Molecular Pathology AI Analysis Software
5.3 Market Segment by Type
5.3.1 World AI Pathology Software Market Size by Type (2021-2026)
5.3.2 World AI Pathology Software Market Size by Type (2027-2032)
5.3.3 World AI Pathology Software Market Size Market Share by Type (2027-2032)
6 MARKET ANALYSIS BY PROCESSING CAPACITY
6.1 World AI Pathology Software Market Size Overview by Processing Capacity: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Processing Capacity
6.2.1 ?500 WSIs/Day
6.2.2 501?5,000 WSIs/Day
6.2.3 >5,000 WSIs/Day
6.3 Market Segment by Processing Capacity
6.3.1 World AI Pathology Software Market Size by Processing Capacity (2021-2026)
6.3.2 World AI Pathology Software Market Size by Processing Capacity (2027-2032)
6.3.3 World AI Pathology Software Market Size Market Share by Processing Capacity (2027-2032)
7 MARKET ANALYSIS BY APPLICATION
7.1 World AI Pathology Software Market Size Overview by Application: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Application
7.2.1 Hospital Pathology Department
7.2.2 Third-party Medical Testing Laboratory
7.2.3 Pharmaceutical R&D
7.3 Market Segment by Application
7.3.1 World AI Pathology Software Market Size by Application (2021-2026)
7.3.2 World AI Pathology Software Market Size by Application (2027-2032)
7.3.3 World AI Pathology Software Market Size Market Share by Application (2021-2032)
8 COMPANY PROFILES
8.1 PathAI, Inc.
8.1.1 PathAI, Inc. Details
8.1.2 PathAI, Inc. Major Business
8.1.3 PathAI, Inc. AI Pathology Software Product and Services
8.1.4 PathAI, Inc. AI Pathology Software Revenue, Gross Margin and Market Share (2021-2026)
8.1.5 PathAI, Inc. Recent Developments/Updates
8.1.6 PathAI, Inc. Competitive Strengths & Weaknesses
8.2 Paige AI, Inc.
8.2.1 Paige AI, Inc. Details
8.2.2 Paige AI, Inc. Major Business
8.2.3 Paige AI, Inc. AI Pathology Software Product and Services
8.2.4 Paige AI, Inc. AI Pathology Software Revenue, Gross Margin and Market Share (2021-2026)
8.2.5 Paige AI, Inc. Recent Developments/Updates
8.2.6 Paige AI, Inc. Competitive Strengths & Weaknesses
8.3 Indica Labs
8.3.1 Indica Labs Details
8.3.2 Indica Labs Major Business
8.3.3 Indica Labs AI Pathology Software Product and Services
8.3.4 Indica Labs AI Pathology Software Revenue, Gross Margin and Market Share (2021-2026)
8.3.5 Indica Labs Recent Developments/Updates
8.3.6 Indica Labs Competitive Strengths & Weaknesses
8.4 Aiforia Technologies Plc
8.4.1 Aiforia Technologies Plc Details
8.4.2 Aiforia Technologies Plc Major Business
8.4.3 Aiforia Technologies Plc AI Pathology Software Product and Services
8.4.4 Aiforia Technologies Plc AI Pathology Software Revenue, Gross Margin and Market Share (2021-2026)
8.4.5 Aiforia Technologies Plc Recent Developments/Updates
8.4.6 Aiforia Technologies Plc Competitive Strengths & Weaknesses
8.5 Ibex Medical Analytics Ltd.
8.5.1 Ibex Medical Analytics Ltd. Details
8.5.2 Ibex Medical Analytics Ltd. Major Business
8.5.3 Ibex Medical Analytics Ltd. AI Pathology Software Product and Services
8.5.4 Ibex Medical Analytics Ltd. AI Pathology Software Revenue, Gross Margin and Market Share (2021-2026)
8.5.5 Ibex Medical Analytics Ltd. Recent Developments/Updates
8.5.6 Ibex Medical Analytics Ltd. Competitive Strengths & Weaknesses
8.6 Proscia Inc.
8.6.1 Proscia Inc. Details
8.6.2 Proscia Inc. Major Business
8.6.3 Proscia Inc. AI Pathology Software Product and Services
8.6.4 Proscia Inc. AI Pathology Software Revenue, Gross Margin and Market Share (2021-2026)
8.6.5 Proscia Inc. Recent Developments/Updates
8.6.6 Proscia Inc. Competitive Strengths & Weaknesses
8.7 Philips
8.7.1 Philips Details
8.7.2 Philips Major Business
8.7.3 Philips AI Pathology Software Product and Services
8.7.4 Philips AI Pathology Software Revenue, Gross Margin and Market Share (2021-2026)
8.7.5 Philips Recent Developments/Updates
8.7.6 Philips Competitive Strengths & Weaknesses
8.8 Roche Diagnostics International Ltd
8.8.1 Roche Diagnostics International Ltd Details
8.8.2 Roche Diagnostics International Ltd Major Business
8.8.3 Roche Diagnostics International Ltd AI Pathology Software Product and Services
8.8.4 Roche Diagnostics International Ltd AI Pathology Software Revenue, Gross Margin and Market Share (2021-2026)
8.8.5 Roche Diagnostics International Ltd Recent Developments/Updates
8.8.6 Roche Diagnostics International Ltd Competitive Strengths & Weaknesses
8.9 Leica Biosystems Nussloch GmbH
8.9.1 Leica Biosystems Nussloch GmbH Details
8.9.2 Leica Biosystems Nussloch GmbH Major Business
8.9.3 Leica Biosystems Nussloch GmbH AI Pathology Software Product and Services
8.9.4 Leica Biosystems Nussloch GmbH AI Pathology Software Revenue, Gross Margin and Market Share (2021-2026)
8.9.5 Leica Biosystems Nussloch GmbH Recent Developments/Updates
8.9.6 Leica Biosystems Nussloch GmbH Competitive Strengths & Weaknesses
8.10 Fujifilm Holdings Corporation
8.10.1 Fujifilm Holdings Corporation Details
8.10.2 Fujifilm Holdings Corporation Major Business
8.10.3 Fujifilm Holdings Corporation AI Pathology Software Product and Services
8.10.4 Fujifilm Holdings Corporation AI Pathology Software Revenue, Gross Margin and Market Share (2021-2026)
8.10.5 Fujifilm Holdings Corporation Recent Developments/Updates
8.10.6 Fujifilm Holdings Corporation Competitive Strengths & Weaknesses
8.11 Visiopharm A/S
8.11.1 Visiopharm A/S Details
8.11.2 Visiopharm A/S Major Business
8.11.3 Visiopharm A/S AI Pathology Software Product and Services
8.11.4 Visiopharm A/S AI Pathology Software Revenue, Gross Margin and Market Share (2021-2026)
8.11.5 Visiopharm A/S Recent Developments/Updates
8.11.6 Visiopharm A/S Competitive Strengths & Weaknesses
8.12 Tempus AI, Inc.
8.12.1 Tempus AI, Inc. Details
8.12.2 Tempus AI, Inc. Major Business
8.12.3 Tempus AI, Inc. AI Pathology Software Product and Services
8.12.4 Tempus AI, Inc. AI Pathology Software Revenue, Gross Margin and Market Share (2021-2026)
8.12.5 Tempus AI, Inc. Recent Developments/Updates
8.12.6 Tempus AI, Inc. Competitive Strengths & Weaknesses
8.13 Yitu Technology Co., Ltd.
8.13.1 Yitu Technology Co., Ltd. Details
8.13.2 Yitu Technology Co., Ltd. Major Business
8.13.3 Yitu Technology Co., Ltd. AI Pathology Software Product and Services
8.13.4 Yitu Technology Co., Ltd. AI Pathology Software Revenue, Gross Margin and Market Share (2021-2026)
8.13.5 Yitu Technology Co., Ltd. Recent Developments/Updates
8.13.6 Yitu Technology Co., Ltd. Competitive Strengths & Weaknesses
8.14 Deepwise Healthcare Technology Co., Ltd.
8.14.1 Deepwise Healthcare Technology Co., Ltd. Details
8.14.2 Deepwise Healthcare Technology Co., Ltd. Major Business
8.14.3 Deepwise Healthcare Technology Co., Ltd. AI Pathology Software Product and Services
8.14.4 Deepwise Healthcare Technology Co., Ltd. AI Pathology Software Revenue, Gross Margin and Market Share (2021-2026)
8.14.5 Deepwise Healthcare Technology Co., Ltd. Recent Developments/Updates
8.14.6 Deepwise Healthcare Technology Co., Ltd. Competitive Strengths & Weaknesses
9 INDUSTRY CHAIN ANALYSIS
9.1 AI Pathology Software Industry Chain
9.2 AI Pathology Software Upstream Analysis
9.3 AI Pathology Software Midstream Analysis
9.4 AI Pathology Software Downstream Analysis
10 RESEARCH FINDINGS AND CONCLUSION
11 APPENDIX
11.1 Methodology
11.2 Research Process and Data Source
11.3 Disclaimer
LIST OF TABLES
Table 1. World AI Pathology Software Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Table 2. World AI Pathology Software Revenue by Region (2021-2026) & (USD Million), (by Headquarter Location)
Table 3. World AI Pathology Software Revenue by Region (2027-2032) & (USD Million), (by Headquarter Location)
Table 4. World AI Pathology Software Revenue Market Share by Region (2021-2026), (by Headquarter Location)
Table 5. World AI Pathology Software Revenue Market Share by Region (2027-2032), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World AI Pathology Software Consumption Value Growth Rate Forecast by Region (2021 & 2025 & 2032) & (USD Million)
Table 8. World AI Pathology Software Consumption Value by Region (2021-2026) & (USD Million)
Table 9. World AI Pathology Software Consumption Value Forecast by Region (2027-2032) & (USD Million)
Table 10. World AI Pathology Software Revenue by Player (2021-2026) & (USD Million)
Table 11. Revenue Market Share of Key AI Pathology Software Players in 2025
Table 12. World AI Pathology Software Industry Rank of Major Player, Based on Revenue in 2025
Table 13. Global AI Pathology Software Company Evaluation Quadrant
Table 14. Head Office of Key AI Pathology Software Players
Table 15. AI Pathology Software Market: Company Product Type Footprint
Table 16. AI Pathology Software Market: Company Product Application Footprint
Table 17. AI Pathology Software Mergers & Acquisitions Activity
Table 18. United States VS China AI Pathology Software Revenue Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 19. United States VS China AI Pathology Software Consumption Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 20. United States Based AI Pathology Software Companies, Headquarters (States, Country)
Table 21. United States Based Companies AI Pathology Software Revenue, (2021-2026) & (USD Million)
Table 22. United States Based Companies AI Pathology Software Revenue Market Share (2021-2026)
Table 23. China Based AI Pathology Software Companies, Headquarters (Province, Country)
Table 24. China Based Companies AI Pathology Software Revenue, (2021-2026) & (USD Million)
Table 25. China Based Companies AI Pathology Software Revenue Market Share (2021-2026)
Table 26. Rest of World Based AI Pathology Software Companies, Headquarters (Province, Country)
Table 27. Rest of World Based Companies AI Pathology Software Revenue (2021-2026) & (USD Million)
Table 28. Rest of World Based Companies AI Pathology Software Revenue Market Share (2021-2026)
Table 29. World AI Pathology Software Market Size by Type, (USD Million), 2021 & 2025 & 2032
Table 30. World AI Pathology Software Market Size Value by Type (2021-2026) & (USD Million)
Table 31. World AI Pathology Software Market Size by Type (2027-2032) & (USD Million)
Table 32. World AI Pathology Software Market Size by Processing Capacity, (USD Million), 2021 & 2025 & 2032
Table 33. World AI Pathology Software Market Size Value by Processing Capacity (2021-2026) & (USD Million)
Table 34. World AI Pathology Software Market Size by Processing Capacity (2027-2032) & (USD Million)
Table 35. World AI Pathology Software Market Size by Application, (USD Million), 2021 & 2025 & 2032
Table 36. World AI Pathology Software Market Size by Application (2021-2026) & (USD Million)
Table 37. World AI Pathology Software Market Size by Application (2027-2032) & (USD Million)
Table 38. PathAI, Inc. Basic Information, Manufacturing Base and Competitors
Table 39. PathAI, Inc. Major Business
Table 40. PathAI, Inc. AI Pathology Software Product and Services
Table 41. PathAI, Inc. AI Pathology Software Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 42. PathAI, Inc. Recent Developments/Updates
Table 43. PathAI, Inc. Competitive Strengths & Weaknesses
Table 44. Paige AI, Inc. Basic Information, Manufacturing Base and Competitors
Table 45. Paige AI, Inc. Major Business
Table 46. Paige AI, Inc. AI Pathology Software Product and Services
Table 47. Paige AI, Inc. AI Pathology Software Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 48. Paige AI, Inc. Recent Developments/Updates
Table 49. Paige AI, Inc. Competitive Strengths & Weaknesses
Table 50. Indica Labs Basic Information, Manufacturing Base and Competitors
Table 51. Indica Labs Major Business
Table 52. Indica Labs AI Pathology Software Product and Services
Table 53. Indica Labs AI Pathology Software Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 54. Indica Labs Recent Developments/Updates
Table 55. Indica Labs Competitive Strengths & Weaknesses
Table 56. Aiforia Technologies Plc Basic Information, Manufacturing Base and Competitors
Table 57. Aiforia Technologies Plc Major Business
Table 58. Aiforia Technologies Plc AI Pathology Software Product and Services
Table 59. Aiforia Technologies Plc AI Pathology Software Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 60. Aiforia Technologies Plc Recent Developments/Updates
Table 61. Aiforia Technologies Plc Competitive Strengths & Weaknesses
Table 62. Ibex Medical Analytics Ltd. Basic Information, Manufacturing Base and Competitors
Table 63. Ibex Medical Analytics Ltd. Major Business
Table 64. Ibex Medical Analytics Ltd. AI Pathology Software Product and Services
Table 65. Ibex Medical Analytics Ltd. AI Pathology Software Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 66. Ibex Medical Analytics Ltd. Recent Developments/Updates
Table 67. Ibex Medical Analytics Ltd. Competitive Strengths & Weaknesses
Table 68. Proscia Inc. Basic Information, Manufacturing Base and Competitors
Table 69. Proscia Inc. Major Business
Table 70. Proscia Inc. AI Pathology Software Product and Services
Table 71. Proscia Inc. AI Pathology Software Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 72. Proscia Inc. Recent Developments/Updates
Table 73. Proscia Inc. Competitive Strengths & Weaknesses
Table 74. Philips Basic Information, Manufacturing Base and Competitors
Table 75. Philips Major Business
Table 76. Philips AI Pathology Software Product and Services
Table 77. Philips AI Pathology Software Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 78. Philips Recent Developments/Updates
Table 79. Philips Competitive Strengths & Weaknesses
Table 80. Roche Diagnostics International Ltd Basic Information, Manufacturing Base and Competitors
Table 81. Roche Diagnostics International Ltd Major Business
Table 82. Roche Diagnostics International Ltd AI Pathology Software Product and Services
Table 83. Roche Diagnostics International Ltd AI Pathology Software Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 84. Roche Diagnostics International Ltd Recent Developments/Updates
Table 85. Roche Diagnostics International Ltd Competitive Strengths & Weaknesses
Table 86. Leica Biosystems Nussloch GmbH Basic Information, Manufacturing Base and Competitors
Table 87. Leica Biosystems Nussloch GmbH Major Business
Table 88. Leica Biosystems Nussloch GmbH AI Pathology Software Product and Services
Table 89. Leica Biosystems Nussloch GmbH AI Pathology Software Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 90. Leica Biosystems Nussloch GmbH Recent Developments/Updates
Table 91. Leica Biosystems Nussloch GmbH Competitive Strengths & Weaknesses
Table 92. Fujifilm Holdings Corporation Basic Information, Manufacturing Base and Competitors
Table 93. Fujifilm Holdings Corporation Major Business
Table 94. Fujifilm Holdings Corporation AI Pathology Software Product and Services
Table 95. Fujifilm Holdings Corporation AI Pathology Software Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 96. Fujifilm Holdings Corporation Recent Developments/Updates
Table 97. Fujifilm Holdings Corporation Competitive Strengths & Weaknesses
Table 98. Visiopharm A/S Basic Information, Manufacturing Base and Competitors
Table 99. Visiopharm A/S Major Business
Table 100. Visiopharm A/S AI Pathology Software Product and Services
Table 101. Visiopharm A/S AI Pathology Software Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 102. Visiopharm A/S Recent Developments/Updates
Table 103. Visiopharm A/S Competitive Strengths & Weaknesses
Table 104. Tempus AI, Inc. Basic Information, Manufacturing Base and Competitors
Table 105. Tempus AI, Inc. Major Business
Table 106. Tempus AI, Inc. AI Pathology Software Product and Services
Table 107. Tempus AI, Inc. AI Pathology Software Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 108. Tempus AI, Inc. Recent Developments/Updates
Table 109. Tempus AI, Inc. Competitive Strengths & Weaknesses
Table 110. Yitu Technology Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 111. Yitu Technology Co., Ltd. Major Business
Table 112. Yitu Technology Co., Ltd. AI Pathology Software Product and Services
Table 113. Yitu Technology Co., Ltd. AI Pathology Software Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 114. Yitu Technology Co., Ltd. Recent Developments/Updates
Table 115. Yitu Technology Co., Ltd. Competitive Strengths & Weaknesses
Table 116. Deepwise Healthcare Technology Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 117. Deepwise Healthcare Technology Co., Ltd. Major Business
Table 118. Deepwise Healthcare Technology Co., Ltd. AI Pathology Software Product and Services
Table 119. Deepwise Healthcare Technology Co., Ltd. AI Pathology Software Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 120. Deepwise Healthcare Technology Co., Ltd. Recent Developments/Updates
Table 121. Deepwise Healthcare Technology Co., Ltd. Competitive Strengths & Weaknesses
Table 122. Global Key Players of AI Pathology Software Upstream (Raw Materials)
Table 123. Global AI Pathology Software Typical Customers
Table 1. World AI Pathology Software Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Table 2. World AI Pathology Software Revenue by Region (2021-2026) & (USD Million), (by Headquarter Location)
Table 3. World AI Pathology Software Revenue by Region (2027-2032) & (USD Million), (by Headquarter Location)
Table 4. World AI Pathology Software Revenue Market Share by Region (2021-2026), (by Headquarter Location)
Table 5. World AI Pathology Software Revenue Market Share by Region (2027-2032), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World AI Pathology Software Consumption Value Growth Rate Forecast by Region (2021 & 2025 & 2032) & (USD Million)
Table 8. World AI Pathology Software Consumption Value by Region (2021-2026) & (USD Million)
Table 9. World AI Pathology Software Consumption Value Forecast by Region (2027-2032) & (USD Million)
Table 10. World AI Pathology Software Revenue by Player (2021-2026) & (USD Million)
Table 11. Revenue Market Share of Key AI Pathology Software Players in 2025
Table 12. World AI Pathology Software Industry Rank of Major Player, Based on Revenue in 2025
Table 13. Global AI Pathology Software Company Evaluation Quadrant
Table 14. Head Office of Key AI Pathology Software Players
Table 15. AI Pathology Software Market: Company Product Type Footprint
Table 16. AI Pathology Software Market: Company Product Application Footprint
Table 17. AI Pathology Software Mergers & Acquisitions Activity
Table 18. United States VS China AI Pathology Software Revenue Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 19. United States VS China AI Pathology Software Consumption Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 20. United States Based AI Pathology Software Companies, Headquarters (States, Country)
Table 21. United States Based Companies AI Pathology Software Revenue, (2021-2026) & (USD Million)
Table 22. United States Based Companies AI Pathology Software Revenue Market Share (2021-2026)
Table 23. China Based AI Pathology Software Companies, Headquarters (Province, Country)
Table 24. China Based Companies AI Pathology Software Revenue, (2021-2026) & (USD Million)
Table 25. China Based Companies AI Pathology Software Revenue Market Share (2021-2026)
Table 26. Rest of World Based AI Pathology Software Companies, Headquarters (Province, Country)
Table 27. Rest of World Based Companies AI Pathology Software Revenue (2021-2026) & (USD Million)
Table 28. Rest of World Based Companies AI Pathology Software Revenue Market Share (2021-2026)
Table 29. World AI Pathology Software Market Size by Type, (USD Million), 2021 & 2025 & 2032
Table 30. World AI Pathology Software Market Size Value by Type (2021-2026) & (USD Million)
Table 31. World AI Pathology Software Market Size by Type (2027-2032) & (USD Million)
Table 32. World AI Pathology Software Market Size by Processing Capacity, (USD Million), 2021 & 2025 & 2032
Table 33. World AI Pathology Software Market Size Value by Processing Capacity (2021-2026) & (USD Million)
Table 34. World AI Pathology Software Market Size by Processing Capacity (2027-2032) & (USD Million)
Table 35. World AI Pathology Software Market Size by Application, (USD Million), 2021 & 2025 & 2032
Table 36. World AI Pathology Software Market Size by Application (2021-2026) & (USD Million)
Table 37. World AI Pathology Software Market Size by Application (2027-2032) & (USD Million)
Table 38. PathAI, Inc. Basic Information, Manufacturing Base and Competitors
Table 39. PathAI, Inc. Major Business
Table 40. PathAI, Inc. AI Pathology Software Product and Services
Table 41. PathAI, Inc. AI Pathology Software Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 42. PathAI, Inc. Recent Developments/Updates
Table 43. PathAI, Inc. Competitive Strengths & Weaknesses
Table 44. Paige AI, Inc. Basic Information, Manufacturing Base and Competitors
Table 45. Paige AI, Inc. Major Business
Table 46. Paige AI, Inc. AI Pathology Software Product and Services
Table 47. Paige AI, Inc. AI Pathology Software Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 48. Paige AI, Inc. Recent Developments/Updates
Table 49. Paige AI, Inc. Competitive Strengths & Weaknesses
Table 50. Indica Labs Basic Information, Manufacturing Base and Competitors
Table 51. Indica Labs Major Business
Table 52. Indica Labs AI Pathology Software Product and Services
Table 53. Indica Labs AI Pathology Software Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 54. Indica Labs Recent Developments/Updates
Table 55. Indica Labs Competitive Strengths & Weaknesses
Table 56. Aiforia Technologies Plc Basic Information, Manufacturing Base and Competitors
Table 57. Aiforia Technologies Plc Major Business
Table 58. Aiforia Technologies Plc AI Pathology Software Product and Services
Table 59. Aiforia Technologies Plc AI Pathology Software Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 60. Aiforia Technologies Plc Recent Developments/Updates
Table 61. Aiforia Technologies Plc Competitive Strengths & Weaknesses
Table 62. Ibex Medical Analytics Ltd. Basic Information, Manufacturing Base and Competitors
Table 63. Ibex Medical Analytics Ltd. Major Business
Table 64. Ibex Medical Analytics Ltd. AI Pathology Software Product and Services
Table 65. Ibex Medical Analytics Ltd. AI Pathology Software Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 66. Ibex Medical Analytics Ltd. Recent Developments/Updates
Table 67. Ibex Medical Analytics Ltd. Competitive Strengths & Weaknesses
Table 68. Proscia Inc. Basic Information, Manufacturing Base and Competitors
Table 69. Proscia Inc. Major Business
Table 70. Proscia Inc. AI Pathology Software Product and Services
Table 71. Proscia Inc. AI Pathology Software Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 72. Proscia Inc. Recent Developments/Updates
Table 73. Proscia Inc. Competitive Strengths & Weaknesses
Table 74. Philips Basic Information, Manufacturing Base and Competitors
Table 75. Philips Major Business
Table 76. Philips AI Pathology Software Product and Services
Table 77. Philips AI Pathology Software Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 78. Philips Recent Developments/Updates
Table 79. Philips Competitive Strengths & Weaknesses
Table 80. Roche Diagnostics International Ltd Basic Information, Manufacturing Base and Competitors
Table 81. Roche Diagnostics International Ltd Major Business
Table 82. Roche Diagnostics International Ltd AI Pathology Software Product and Services
Table 83. Roche Diagnostics International Ltd AI Pathology Software Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 84. Roche Diagnostics International Ltd Recent Developments/Updates
Table 85. Roche Diagnostics International Ltd Competitive Strengths & Weaknesses
Table 86. Leica Biosystems Nussloch GmbH Basic Information, Manufacturing Base and Competitors
Table 87. Leica Biosystems Nussloch GmbH Major Business
Table 88. Leica Biosystems Nussloch GmbH AI Pathology Software Product and Services
Table 89. Leica Biosystems Nussloch GmbH AI Pathology Software Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 90. Leica Biosystems Nussloch GmbH Recent Developments/Updates
Table 91. Leica Biosystems Nussloch GmbH Competitive Strengths & Weaknesses
Table 92. Fujifilm Holdings Corporation Basic Information, Manufacturing Base and Competitors
Table 93. Fujifilm Holdings Corporation Major Business
Table 94. Fujifilm Holdings Corporation AI Pathology Software Product and Services
Table 95. Fujifilm Holdings Corporation AI Pathology Software Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 96. Fujifilm Holdings Corporation Recent Developments/Updates
Table 97. Fujifilm Holdings Corporation Competitive Strengths & Weaknesses
Table 98. Visiopharm A/S Basic Information, Manufacturing Base and Competitors
Table 99. Visiopharm A/S Major Business
Table 100. Visiopharm A/S AI Pathology Software Product and Services
Table 101. Visiopharm A/S AI Pathology Software Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 102. Visiopharm A/S Recent Developments/Updates
Table 103. Visiopharm A/S Competitive Strengths & Weaknesses
Table 104. Tempus AI, Inc. Basic Information, Manufacturing Base and Competitors
Table 105. Tempus AI, Inc. Major Business
Table 106. Tempus AI, Inc. AI Pathology Software Product and Services
Table 107. Tempus AI, Inc. AI Pathology Software Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 108. Tempus AI, Inc. Recent Developments/Updates
Table 109. Tempus AI, Inc. Competitive Strengths & Weaknesses
Table 110. Yitu Technology Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 111. Yitu Technology Co., Ltd. Major Business
Table 112. Yitu Technology Co., Ltd. AI Pathology Software Product and Services
Table 113. Yitu Technology Co., Ltd. AI Pathology Software Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 114. Yitu Technology Co., Ltd. Recent Developments/Updates
Table 115. Yitu Technology Co., Ltd. Competitive Strengths & Weaknesses
Table 116. Deepwise Healthcare Technology Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 117. Deepwise Healthcare Technology Co., Ltd. Major Business
Table 118. Deepwise Healthcare Technology Co., Ltd. AI Pathology Software Product and Services
Table 119. Deepwise Healthcare Technology Co., Ltd. AI Pathology Software Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 120. Deepwise Healthcare Technology Co., Ltd. Recent Developments/Updates
Table 121. Deepwise Healthcare Technology Co., Ltd. Competitive Strengths & Weaknesses
Table 122. Global Key Players of AI Pathology Software Upstream (Raw Materials)
Table 123. Global AI Pathology Software Typical Customers
LIST OF FIGURES
Figure 1. AI Pathology Software Picture
Figure 2. World AI Pathology Software Total Revenue: 2021 & 2025 & 2032, (USD Million)
Figure 3. World AI Pathology Software Total Revenue (2021-2032) & (USD Million)
Figure 4. World AI Pathology Software Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Figure 5. World AI Pathology Software Revenue Market Share by Region (2021-2032), (by Headquarter Location)
Figure 6. United States Based Company AI Pathology Software Revenue (2021-2032) & (USD Million)
Figure 7. China Based Company AI Pathology Software Revenue (2021-2032) & (USD Million)
Figure 8. Europe Based Company AI Pathology Software Revenue (2021-2032) & (USD Million)
Figure 9. Japan Based Company AI Pathology Software Revenue (2021-2032) & (USD Million)
Figure 10. South Korea Based Company AI Pathology Software Revenue (2021-2032) & (USD Million)
Figure 11. ASEAN Based Company AI Pathology Software Revenue (2021-2032) & (USD Million)
Figure 12. India Based Company AI Pathology Software Revenue (2021-2032) & (USD Million)
Figure 13. AI Pathology Software Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World AI Pathology Software Consumption Value (2021-2032) & (USD Million)
Figure 16. World AI Pathology Software Consumption Value Market Share by Region (2021-2032)
Figure 17. United States AI Pathology Software Consumption Value (2021-2032) & (USD Million)
Figure 18. China AI Pathology Software Consumption Value (2021-2032) & (USD Million)
Figure 19. Europe AI Pathology Software Consumption Value (2021-2032) & (USD Million)
Figure 20. Japan AI Pathology Software Consumption Value (2021-2032) & (USD Million)
Figure 21. South Korea AI Pathology Software Consumption Value (2021-2032) & (USD Million)
Figure 22. ASEAN AI Pathology Software Consumption Value (2021-2032) & (USD Million)
Figure 23. India AI Pathology Software Consumption Value (2021-2032) & (USD Million)
Figure 24. Producer Shipments of AI Pathology Software by Player Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for AI Pathology Software Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for AI Pathology Software Markets in 2025
Figure 27. United States VS China: AI Pathology Software Revenue Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: AI Pathology Software Consumption Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. World AI Pathology Software Market Size by Type, (USD Million), 2021 & 2025 & 2032
Figure 30. World AI Pathology Software Market Size Market Share by Type in 2025
Figure 31. Histopathology AI Analysis Software
Figure 32. Cytopathology AI Analysis Software
Figure 33. Immunohistochemistry AI Analysis Software
Figure 34. Molecular Pathology AI Analysis Software
Figure 35. World AI Pathology Software Market Size Market Share by Type (2021-2032)
Figure 36. World AI Pathology Software Market Size by Processing Capacity, (USD Million), 2021 & 2025 & 2032
Figure 37. World AI Pathology Software Market Size Market Share by Processing Capacity in 2025
Figure 38. ?500 WSIs/Day
Figure 39. 501?5,000 WSIs/Day
Figure 40. >5,000 WSIs/Day
Figure 41. World AI Pathology Software Market Size Market Share by Processing Capacity (2021-2032)
Figure 42. World AI Pathology Software Market Size by Application, (USD Million), 2021 & 2025 & 2032
Figure 43. World AI Pathology Software Market Size Market Share by Application in 2025
Figure 44. Hospital Pathology Department
Figure 45. Third-party Medical Testing Laboratory
Figure 46. Pharmaceutical R&D
Figure 47. World AI Pathology Software Market Size Market Share by Application (2021-2032)
Figure 48. AI Pathology Software Industrial Chain
Figure 49. Methodology
Figure 50. Research Process and Data Source
Figure 1. AI Pathology Software Picture
Figure 2. World AI Pathology Software Total Revenue: 2021 & 2025 & 2032, (USD Million)
Figure 3. World AI Pathology Software Total Revenue (2021-2032) & (USD Million)
Figure 4. World AI Pathology Software Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Figure 5. World AI Pathology Software Revenue Market Share by Region (2021-2032), (by Headquarter Location)
Figure 6. United States Based Company AI Pathology Software Revenue (2021-2032) & (USD Million)
Figure 7. China Based Company AI Pathology Software Revenue (2021-2032) & (USD Million)
Figure 8. Europe Based Company AI Pathology Software Revenue (2021-2032) & (USD Million)
Figure 9. Japan Based Company AI Pathology Software Revenue (2021-2032) & (USD Million)
Figure 10. South Korea Based Company AI Pathology Software Revenue (2021-2032) & (USD Million)
Figure 11. ASEAN Based Company AI Pathology Software Revenue (2021-2032) & (USD Million)
Figure 12. India Based Company AI Pathology Software Revenue (2021-2032) & (USD Million)
Figure 13. AI Pathology Software Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World AI Pathology Software Consumption Value (2021-2032) & (USD Million)
Figure 16. World AI Pathology Software Consumption Value Market Share by Region (2021-2032)
Figure 17. United States AI Pathology Software Consumption Value (2021-2032) & (USD Million)
Figure 18. China AI Pathology Software Consumption Value (2021-2032) & (USD Million)
Figure 19. Europe AI Pathology Software Consumption Value (2021-2032) & (USD Million)
Figure 20. Japan AI Pathology Software Consumption Value (2021-2032) & (USD Million)
Figure 21. South Korea AI Pathology Software Consumption Value (2021-2032) & (USD Million)
Figure 22. ASEAN AI Pathology Software Consumption Value (2021-2032) & (USD Million)
Figure 23. India AI Pathology Software Consumption Value (2021-2032) & (USD Million)
Figure 24. Producer Shipments of AI Pathology Software by Player Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for AI Pathology Software Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for AI Pathology Software Markets in 2025
Figure 27. United States VS China: AI Pathology Software Revenue Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: AI Pathology Software Consumption Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. World AI Pathology Software Market Size by Type, (USD Million), 2021 & 2025 & 2032
Figure 30. World AI Pathology Software Market Size Market Share by Type in 2025
Figure 31. Histopathology AI Analysis Software
Figure 32. Cytopathology AI Analysis Software
Figure 33. Immunohistochemistry AI Analysis Software
Figure 34. Molecular Pathology AI Analysis Software
Figure 35. World AI Pathology Software Market Size Market Share by Type (2021-2032)
Figure 36. World AI Pathology Software Market Size by Processing Capacity, (USD Million), 2021 & 2025 & 2032
Figure 37. World AI Pathology Software Market Size Market Share by Processing Capacity in 2025
Figure 38. ?500 WSIs/Day
Figure 39. 501?5,000 WSIs/Day
Figure 40. >5,000 WSIs/Day
Figure 41. World AI Pathology Software Market Size Market Share by Processing Capacity (2021-2032)
Figure 42. World AI Pathology Software Market Size by Application, (USD Million), 2021 & 2025 & 2032
Figure 43. World AI Pathology Software Market Size Market Share by Application in 2025
Figure 44. Hospital Pathology Department
Figure 45. Third-party Medical Testing Laboratory
Figure 46. Pharmaceutical R&D
Figure 47. World AI Pathology Software Market Size Market Share by Application (2021-2032)
Figure 48. AI Pathology Software Industrial Chain
Figure 49. Methodology
Figure 50. Research Process and Data Source
